Pulse Explore Journal Club Debates Trending Researchers

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Home Explore Journal Club Trending

⌘+K

The SU.VI.MAX Study | Synapse

November 22, 2004

View Full Paper

The SU.VI.MAX Study

Serge HerçbergPreventive Cardiology PGPilar GalánUniversité Paris-Sud PPPaul PreziosiConservatoire National des Arts et Métiers

Key Points

Key points are not available for this paper at this time.

Abstract

After 7.5 years, low-dose antioxidant supplementation lowered total cancer incidence and all-cause mortality in men but not in women. Supplementation may be effective in men only because of their lower baseline status of certain antioxidants, especially of beta carotene.

Ask AI

Helpful

Bookmark

Share

View Full Paper

Ask AI

Helpful

Bookmark

Share

View Full Paper

Cite This Study

Herçberg et al. (Mon,) studied this question.

synapsesocial.com/papers/69d9aa5500ab073a2783727d https://doi.org/https://doi.org/10.1001/archinte.164.21.2335

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A Primary Prevention Trial Using Nutritional Doses of Antioxidant Vitamins and Minerals in Cardiovascular Diseases and Cancers in a General Population1998 · 356 citations
2Background and rationale behind the SU.VI.MAX Study, a prevention trial using nutritional doses of a combination of antioxidant vitamins and minerals to reduce cardiovascular diseases and cancers. SUpplementation en VItamines et Minéraux AntioXydants Study.1998 · 173 citations
3Antioxidant nutrients and disease prevention: an overview1991 · 342 citations
4Recommended method for assaying serum zinc with flame atomic absorption.1986 · 59 citations
5A European multicentre, placebo-controlled supplementation study with α-tocopherol, carotene-rich palm oil, lutein or lycopene: analysis of serum responses2002 · 80 citations